Genmab and Seagen Present Interim Results From the innovaTV 205 Study for Tisotumab Vedotin Combination Therapy Treatment of Recurrent or Metastatic Cervical Cancer at ESMO Virtual Congress 2021
September 19, 2021 11:30 ET
|
Genmab A/S
Media Release Tisotumab Vedotin in Combination with Carboplatin Showed Encouraging, Durable Anti-Tumor Activity as First-Line Treatment Tisotumab Vedotin in Combination with Pembrolizumab Showed...
Novartis presents new Kisqali® data showing longest median overall survival ever reported in HR+/HER2- advanced breast cancer
September 19, 2021 07:30 ET
|
Novartis Pharma AG
With the MONALEESA-2 final analysis, only Kisqali has reported statistically significant overall survival (OS) benefit with an aromatase inhibitor for postmenopausal women with HR+/HER2- advanced...
Transaction in Own Shares
September 17, 2021 12:58 ET
|
Shell International B.V.
Transaction in Own Shares 17 September 2021 • • • • • • • • • • • • • • • • Royal Dutch Shell plc (the ‘Company’) announces that on 17 September 2021 it purchased the following number of 'B'...
Director/PDMR Shareholding
September 17, 2021 11:29 ET
|
Admiral Group PLC
NOTIFICATION OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM 1Details of the person discharging managerial responsibilities (PDMR)/person...
J.P. Morgan Structured Products B.V. 2021 Interim Financial Statements
September 17, 2021 11:00 ET
|
J.P. Morgan Structured Products B.V.
J.P. Morgan Structured Products B.V. 2021 Interim Financial Statements
Attachment
JPMSPBV UNSIGNED 2021 Semi Annual Accounts (unaudited)
...
Middlefield Canadian Income PCC: Net Asset Value(s)
September 17, 2021 10:50 ET
|
Middlefield Canadian Income PCC
Middlefield Canadian Income PCC Net Asset Value Middlefield Canadian Income PCC Middlefield Canadian Income - GBP PC (a protected cell company incorporated in Jersey...
Davidson Kempner Capital Management LP : Form 8.3 - Meggitt plc
September 17, 2021 10:20 ET
|
Davidson Kempner Capital Management LP
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) ...
MaxCyte Set to Join Russell 2000® Index
September 17, 2021 08:35 ET
|
MaxCyte, Inc
GAITHERSBURG, Md., Sept. 17, 2021 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (NASDAQ: MXCT; LSE: MXCT, MXCN), a leading commercial cell-engineering company focused on providing enabling platform...
Alliance Trust PLC - Net Asset Value
September 17, 2021 08:29 ET
|
Alliance Trust Plc
ALLIANCE TRUST PLC At the close of business Thursday 16 September 2021: The Company’s NAV per ordinary share, valued on a bid price basis with Debt at Par, was - excluding income,...
Novartis announces findings from a real-world study of alpelisib demonstrating clinical benefit in people with PIK3CA-Related Overgrowth Spectrum (PROS)
September 17, 2021 07:30 ET
|
Novartis Pharma AG
PROS is a spectrum of rare disorders caused by PIK3CA mutations and is characterized by atypical, visible overgrowths and anomalies in blood vessels, the lymphatic system and other tissuesAt 24 weeks,...